The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 5, 2002, Pages 935-938

  Kaneda, Yasuhiro ^a,b   Fujii, Akira ^b   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Fujii Hospital   (Japan)

Author keywords

ACTH; Corticotropin; Cortisol; Neuroleptic; Schizophrenia

Indexed keywords

ACETYLCHOLINE; CORTICOTROPIN; HYDROCORTISONE; NEUROLEPTIC AGENT;

ACETYLCHOLINE RELEASE; ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFORMED CONSENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CHRONIC DISEASE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 0036592395     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00208-7     Document Type: Article

References (28)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 1994;American Psychiatric Association, Washington, DC.
2. 2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology. 31:1992;671-678.
3. Brambilla F., Guerrini A., Guastalla A., Rovere C., Riggi F. Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia. 44:1975;17-22.
4. Crow T.J. The two-syndrome concept: origins and current status. Schizophr. Bull. 11:1985;471-486.
5. Debreceni L., Csonka-Takács L., Horváth P., Csete B. The effect of chronic droperidol treatment on pituitary-adrenocortical function in the rat. Acta Physiol. Acad. Sci. Hung. 40:1971;235-238.
6. Debreceni L., Tényi I., Csete B., Csonka-Takács L. The effect of dehydrobenzperidol, chlorpromazine and reserpine on the pituitary-adrenal system in human. Endokrinologie. 58:1971;410-413.
7. De Wied D. Chlorpromazine and endocrine function. Pharmacol. Rev. 19:1967;251-288.
8. Elman I., Adler C.M., Malhotra A.K., Bir C., Pickar D., Breier A. Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. Am. J. Psychiatry. 155:1998;979-981.
9. Franzén G. Serum cortisol in chronic schizophrenia. Changes in the diurnal rhythm and psychiatric mental status on withdrawal of drugs. Psychiatr. Clin. (Basel). 4:1971;237-246.
10. Fukuchi M., Matsuo Y., Murakami M., Omote M., Kawanaka M., Matsushima H. Fundamental and clinical evaluation of IRMA for plasma ACTH (1-39) Kaku Igaku. Jpn. J. Nucl. Med. 27:1990;155-163. in Japanese.
11. Guy W. ECDU Assessment Manual. 1976;U.S. Department of Health Education and Welfare, Rockville, MD.
12. Hirata Y., Nakashima H., Uchihashi M., Tomita M., Fujita T., Ikeda M. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF) induced ACTH release in a patient with Nelson's syndrome. Endocrinol. Jpn. 31:1984;619-626.
13. Inagaki A., Inada T., Fujii Y., Yagi K. Dose equivalence of psychotropic drugs: Part 4. Dose equivalence of orally administered neuroleptics (4) Rinsyo Seisin Yakuri. Jpn. J. Clin. Psychopharmacol. 1:1998;443-448. in Japanese.
14. Inagaki A., Inada T., Fujii Y., Yagi K. Dose equivalence of psychotropic drugs: Part 6. Dose equivalence of depot administered neuroleptics (2) Rinsyo Seisin Yakuri. Jpn. J. Clin. Psychopharmacol. 1:1998;557-561. in Japanese.
15. Jansen L.M., Gispen-de Wied C.C., Gademan P.J., De Jonge R.C., van der Linden J.A., Kahn R.S. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr. Res. 33:1998;87-94.
16. Jêzová D., Kvetnansky R., Vigas M. Sex differences in endocrine response to hyperthermia in sauna. Acta Physiol. Scand. 150:1994;293-298.
17. Kaneko M., Yokoyama F., Hoshino Y., Takahagi K., Murata S., Watanabe M., Kumashiro H. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features. Neuropsychobiology. 25:1992;1-7.
18. Kitamura T., Shima S., Kato M., Iwashita S., Kanba S., Shiratsuchi T., Fujihara S., Ikuta Y., Kato M., Kanba K., Iino T., Ikuta N., Miyaoka H., Takei S., Hiyama M., Koshikawa H., Tsugeno M., Chiba C. Positive and negative symptoms of chronic schizophrenia Seishin Igaku. Clin. Psychiatry 31:1989;131-136. in Japanese.
19. Lerer B., Ran A., Blacker M., Silver H., Weller M.P., Drummer D., Ebstein B., Calev A. Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction. Schizophr. Res. 1:1988;405-410.
20. Nakazato K., Mizuguchi T. Development and validation of Japanese version of State-Trait Anxiety Inventory: a study with female subjects Shinshin Igaku. Jpn. J. Psychosom. Med. 22:1982;107-112. in Japanese.
21. Nicholson I.R., Chapman J.E., Neufeld R.W. Variability in BPRS definitions of positive and negative symptoms. Schizophr. Res. 17:1995;177-185.
22. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:1962;799-812.
23. Roy A., Pickar D., Doran A., Wolkowitz O., Gallucci W., Chrousos G., Gold P. The corticotropin-releasing hormone stimulation test in chronic schizophrenia. Am. J. Psychiatry. 143:1986;1393-1397.
24. Saffer D., Metcalfe M., Coppen A. Abnormal dexamethasone suppression test in type II schizophrenia. Br. J. Psychiatry. 147:1985;721-723.
25. Seki K., Mitsui C., Nagata I. Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women. Gynecol. Obstet. Invest. 40:1995;42-45.
26. Spielberger C.D., Gorsuch R.L., Lushene R.E. STAI Manual. 1970;Consulting Psychologists Press, Palo Alto, CA.
27. Suzuki S., Nakagawa S., Toyosaki I. Fundamental evaluation and clinical application of plasma and urinary cortisol by fluorescence polarization immunoassay (TDx) Igaku To Yakugaku. J. Med. 17:1987;659-668. in Japanese.
28. Tandon R., Mazzara C., DeQuardo J., Craig K.A., Meador-Woodruff J.H., Goldman R., Greden J.F. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol. Psychiatry. 29:1991;953-964.